Aclaris Therapeutics (0H8T.LSE) Q3 2024 Earnings

Aug 7Confirmed
Q2 2024
Q3 2024
-0.29
-0.24
-0.2
-0.15

Details

Expected EPS
-0.2047
Actual EPS
-0.15
Surprise EPS
0.05
Surprise Percent
+26.72%

Description

⁨Aclaris Therapeutics⁩ (⁦0H8T.LSE⁩) has reported earnings of ⁦-0.15⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts